Colleen Kusy
Stock Analyst at Baird
(3.25)
Main Sectors:
Top Industries:
18 Stocks
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CLYM Climb Bio | Initiates Coverage On: Outperform | 9 | 2.13 | 322.54% | 1 | Aug 15, 2025 | |
APLS Apellis Pharmaceutic... | Maintains: Outperform | 47 50 | 22.37 | 123.51% | 12 | Jul 18, 2025 | |
NUVL Nuvalent | Maintains: Outperform | 105 112 | 81.39 | 37.61% | 2 | Jun 25, 2025 | |
ELVN Enliven Therapeutics | Maintains: Outperform | 40 52 | 20.01 | 159.87% | 3 | Jun 16, 2025 | |
AGEN Agenus | Maintains: Neutral | 4 6 | 3.95 | 51.9% | 4 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 37 41 | 17.63 | 132.56% | 4 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 4 6 | 1.5 | 300% | 5 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 50 65 | 16.24 | 300.25% | 2 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 100 75 | 7.57 | 890.75% | 4 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 18 17 | 12.53 | 35.67% | 4 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 27 25 | 11.12 | 124.82% | 1 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 6 | Jun 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 40 | n/a | n/a | 3 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 17 15 | n/a | n/a | 1 | Oct 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 255 210 | 6.55 | 3106.11% | 1 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 30 34 | 2.11 | 1511.37% | 5 | Apr 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 230 | 2.01 | 11342.79% | 1 | Nov 2, 2021 |